AI Framework for Predicting Neurological Treatment Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to reliably predict individualized responses to treatments for neurological conditions like epilepsy and Parkinson's disease, as existing biomarkers and clinical predictors are inadequate for informing personalized medication prescriptions.
Innovation Solution
An AI framework combining machine learning ensemble methods with Bayesian statistical modeling is used to analyze patient-specific neuroimaging, clinical, and biological data, selecting relevant variables to predict treatment responses and potential adverse events, thereby addressing the limitations of high-dimensional data and overfitting.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If univariate analysis of clinical or molecular biomarkers is used, then the method is simple and easy to implement, but it fails to predict individualized response to AED treatment
Solution Approach 1:
The patent combines multiple data sources including EEG features, clinical characteristics, and molecular biomarkers into a unified multivariable predictive model. This integration allows the system to capture complex interactions between different factors that influence treatment response, thereby improving predictive accuracy while maintaining operational feasibility through automated processing.
Solution Approach 2:
The predictive model functions as a composite analytical system that integrates diverse data types (electrophysiological, clinical, molecular) into a unified predictive framework. This composite approach leverages the complementary strengths of each data source to achieve reliable individualized treatment response prediction that univariate methods cannot accomplish.
2Reliability
If multivariable methods are used to analyze high-dimensional data, then predictive accuracy improves, but the complexity of the system increases
Solution Approach 1:
The patent segments the high-dimensional data analysis into distinct processing stages: EEG signal acquisition and feature extraction, clinical data collection and processing, molecular biomarker analysis, and integrated predictive modeling. This segmentation allows each component to be optimized independently while maintaining overall system manageability and interpretability.
Solution Approach 2:
The system introduces intermediate processing layers including feature extraction from raw EEG signals, data normalization and standardization, and intermediate scoring systems that translate complex multivariable interactions into interpretable predictive metrics. These intermediaries bridge the gap between complex data inputs and clinically actionable predictions.
3Measurement precision
If EEG data is used to improve signal quality and spatial precision, then measurement accuracy improves, but the dimensionality of data increases making analysis more difficult
Solution Approach 1:
The patent extracts relevant features from high-dimensional EEG data by identifying and isolating specific signal characteristics that are most predictive of treatment response. This includes extracting spectral features, spatial patterns, and temporal dynamics that capture essential information while discarding redundant dimensions, thereby reducing data complexity while maintaining measurement precision.
Solution Approach 2:
The system transforms high-dimensional raw EEG signals into lower-dimensional feature spaces through dimensional reduction techniques. By projecting complex multivariate EEG data onto fewer latent dimensions that capture the most relevant variance, the system maintains measurement precision while making the data more tractable for predictive modeling.
Data Source
AI summary
A method is provided for constructing a machine learning algorithm for predicting a response variable for a neurological condition. The method includes extracting variables for characterizing a patient cohort from electronic historical medical data; selecting variables from the extracted variables using a random forest defined by an initial response variable; fitting a Bayesian generalized linear mixed model (GLMM) using the initial response variable; extracting a predictive probability from the Bayesian GLMM for each of the selected variables; determining a target response variable from the predictive probability and the initial response variable; using the random forest and the Bayesian GLMM to obtain final estimated predictive probabilities based on target response variable for each of the selected variables to identify relevant selected variables; and constructing the machine learning algorithm to utilize the relevant selected variables for predicting the response variable for the neurological condition.